Compare Micron Technology, Inc. (MU) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Micron Technology, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Micron Technology, Inc. trades at $983.86 (market cap $977.44B), while State Street SPDR S&P Biotech ETF trades at $154.5. The key difference: Micron Technology, Inc. pays a 0.06% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| MU | XBI | |
|---|---|---|
Market Cap | $977.44B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $1.21K | $164.28 |
52-Week Low | $104.88 | $85.16 |
Enterprise Value | $957.80B | — |
Dividend Yield | 0.06% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Micron Technology, Inc.
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
